Security of Supply Requires Proactive Measures
The first part of this series of articles focused on the early detection and assessment of potential supply disruptions, whilst the second part dealt with resilient communication chains. The third part now addresses what is perhaps the most far-reaching aspect of the Q&A paper from the European Commission: the commitment to prevention, mitigation and adaptation.
The Commission makes it clear that the requirements of Article 10a of the EU MDR do not end with monitoring and reporting. Manufacturers should actively address identified risks and take appropriate measures to prevent supply disruptions where possible or to limit their impact.
As a result, the regulatory focus is increasingly shifting towards preventive risk management. Companies are expected not only to share information, but also to draw up robust strategies that can effectively mitigate supply and production disruptions. The Commission therefore makes it clear that:
Point 3: Active, Dynamic Mitigation rather than Passivity and Routine Reporting
The Commission’s requirements go beyond the monitoring and reporting of bottlenecks and production stoppages:
Once manufacturers have realised that production bottlenecks are occurring, they have a duty to do their utmost to counteract them.
To this end, manufacturers should first ensure – particularly in the case of critical products where the manufacturer in question accounts for a high market share (i.e. where a shortage of such products would lead to significant supply bottlenecks – see point 1) – that alternative supply channels are available.
These include sourcing stock, liaising with other manufacturers with a comparable product range, adapting production, and procuring the components and the product in question. It is crucial that these adaptation strategies are not only drawn up at the moment of crisis, but that manufacturers demonstrably prepare for such emergencies in advance.
The good news is that if there is a watertight contingency plan in place, it may not be necessary to report the supply disruption. In such cases, the disruption effectively resolves itself – so maintaining a diverse mix of production and acquisition activities remains the best contingency plan.
As a rule of thumb, manufacturers might ask themselves:
Have I assessed and implemented all realistic measures to prevent or mitigate a supply shortage – and can I explain why any residual risks are acceptable or unavoidable?
It may be useful to distinguish between three categories of countermeasures:
Preventive measures aim to avoid production downtime before it occurs – for example, by using backup suppliers.
Mitigating measures are designed to ensure that supply disruptions do not have serious consequences. For example, if a product can be manufactured using alternative raw materials or components, or if a substitute product with a similar purpose and benefit is available.
Adaptive measures are closely related to mitigative measures. Here, however, they refer to steps that are taken outside the company. If, for example, there are other manufacturers with a comparable product whose production capacities are not restricted, their stocks can be drawn upon in an emergency.
Through Thick and Thin: BEO BERLIN by Your Side
Increasing regulatory requirements, geopolitical uncertainties and volatile supply chains are putting growing pressure on medical device manufacturers to ensure the reliability of their supply and supply chain. At the same time, digital quality management systems, structured vigilance processes and robust standard operating procedures now enable potential supply disruptions to be identified and mitigated at a much earlier stage.
BEO BERLIN supports medical device manufacturers in establishing robust communication, vigilance and risk management systems in accordance with the EU MDR. The aim is not merely to meet regulatory requirements, but to develop resilient processes to safeguard production, delivery capacity and market supply in the long term.
Because today, more than ever, resilience is a competitive advantage.
This is Part 3: Countermeasures.
Click here for Part 1: Surveillance.
And here is Part 2: Communication.
(No ratings yet)
Loading...
